Related Experiment Video
Updated: Jun 6, 2026
08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Chronic inflammation, colorectal cancer and gene polymorphisms
1Division of Gastroenterology, Baylor University Medical Center, GI Cancer Research Laboratory, Dallas, TX 75246, USA. rickbo@baylorhealth.edu
Digestive Diseases (Basel, Switzerland)
|November 20, 2010
Summary
Chronic inflammation increases cancer risk in the gut, but predicting individual susceptibility remains challenging. Understanding gene interactions and environmental factors is key to personalized risk assessment for gastrointestinal cancers.
Area of Science:
- Gastroenterology
- Genetics
- Oncology
Background:
- Chronic inflammation in the gastrointestinal tract, seen in inflammatory bowel disease (IBD) and H. pylori gastritis, elevates cancer risk.
- Current understanding of cancer development in chronic inflammation lacks clarity regarding individual risk prediction.
- Unlike familial colorectal cancer (CRC), IBD and other chronic inflammatory conditions are not typically linked to single high-penetrance gene mutations.
Purpose of the Study:
- To explore the genetic underpinnings of variable inflammation and cancer development in the gut.
- To investigate the role of single nucleotide polymorphisms (SNPs) in chronic gastrointestinal inflammation and associated cancer risks.
- To highlight the need for understanding gene-gene interactions (epistasis) and environmental factors in personalized risk assessment.
Main Methods:
- Utilized genome-wide association studies (GWAS) to identify genetic variations (SNPs) associated with phenotypes like chronic inflammation and cancer.
- Reviewed existing literature linking specific genetic loci (e.g., NOD2, IL23R, ATG16L1) to inflammatory bowel disease.
- Discussed the complexity arising from numerous SNPs with modest individual effects.
Main Results:
- Identified multiple SNPs associated with IBD risk, including those in bacterial response genes (NOD2), immune regulation (IL23R), and autophagy (ATG16L1).
- Highlighted that numerous genetic polymorphisms contribute to chronic inflammation risk, each with a relatively small individual impact.
- Emphasized the challenge in predicting cancer risk due to the complex interplay of multiple genetic factors.
Conclusions:
- Predicting chronic inflammation and associated cancer risk is complicated by the additive and interactive effects of numerous genetic polymorphisms.
- Integrating knowledge of SNP interactions (epistasis) with environmental exposures is crucial for personalized risk assessment.
- Informatics science offers a promising avenue for developing personalized strategies to manage chronic gut inflammation and identify individuals at high risk for cancer.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...